Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.

Frontotemporal dementia can be hard to diagnose because while dementia can be part of the illness, it's not a factor in all ...

Longview residents were out in front of the Gregg County Courthouse on Saturday to take part in the Walk to End Alzheimer’s ...

Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

Researchers at Indiana University School of Medicine are examining the brains of individuals with asymptomatic Alzheimer's ...

Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...

Scientists have announced a significant breakthrough in the development of a drug to combat Alzheimer's disease. The drug, ...

Researchers intrigued by people with hallmarks of Alzheimer’s disease — but none of the symptoms — have probed their brains in the search for a cure. They initially drew samples from the Netherlands ...

On Sunday was the walk to end Alzheimer’s event at the Meadowbrook mall. Where people can walk or donate money to help with ...

Those with Alzheimer's Disease may suffer from delusions, false beliefs and paranoia. Memory-related symptoms of the disease, such as misplacing and losing things can become confusing, which may cause ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.